Helen E. Collins Laboratory

Investigating Mechanisms Underlying Female Cardiovascular Resilience and Health

Protein O-GlcNAcylation and Cardiovascular (Patho)physiology*


Journal article


S. A. Marsh, Helen E Collins, J. Chatham
The Journal of Biological Chemistry, 2014

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Marsh, S. A., Collins, H. E., & Chatham, J. (2014). Protein O-GlcNAcylation and Cardiovascular (Patho)physiology*. The Journal of Biological Chemistry.


Chicago/Turabian   Click to copy
Marsh, S. A., Helen E Collins, and J. Chatham. “Protein O-GlcNAcylation and Cardiovascular (Patho)Physiology*.” The Journal of Biological Chemistry (2014).


MLA   Click to copy
Marsh, S. A., et al. “Protein O-GlcNAcylation and Cardiovascular (Patho)Physiology*.” The Journal of Biological Chemistry, 2014.


BibTeX   Click to copy

@article{s2014a,
  title = {Protein O-GlcNAcylation and Cardiovascular (Patho)physiology*},
  year = {2014},
  journal = {The Journal of Biological Chemistry},
  author = {Marsh, S. A. and Collins, Helen E and Chatham, J.}
}

Abstract

Our understanding of the role of protein O-GlcNAcylation in the regulation of the cardiovascular system has increased rapidly in recent years. Studies have linked increased O-GlcNAc levels to glucose toxicity and diabetic complications; conversely, acute activation of O-GlcNAcylation has been shown to be cardioprotective. However, it is also increasingly evident that O-GlcNAc turnover plays a central role in the delicate regulation of the cardiovascular system. Therefore, the goals of this minireview are to summarize our current understanding of how changes in O-GlcNAcylation influence cardiovascular pathophysiology and to highlight the evidence that O-GlcNAc cycling is critical for normal function of the cardiovascular system.


Share


Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in